Spotlight
Clinical
Video Series
News
Publication
CME/CE
Partners
Sarah L. Spitznogle, PharmD*
Articles
Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens
October 14th 2019Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.
Read More
